To assess the capability of Gel@Cmab/PCZ in enhancing ADCC effects in more clinically oriented models, therapeutic studies were carried out on NK cell‐humanized NCG mice with EGFR‐internalization CRC‐PDX model to evaluate ADCC in vivo (Figure 6A). This evidence concerns the gene EGFR and colorectal carcinoma.